Takeda Pharmaceutical (TAK) News Today $15.20 -0.18 (-1.17%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$15.17 -0.03 (-0.20%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Novavax, Inc.: Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in JapanMay 5 at 4:37 PM | finanznachrichten.deNovavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In JapanMay 5 at 11:36 AM | finanznachrichten.deTakeda Pharmaceutical Company Limited (NYSE:TAK) Stock Position Lifted by Tower Research Capital LLC TRCTower Research Capital LLC TRC lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 413.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20May 5 at 4:04 AM | marketbeat.comRaymond James Financial Inc. Purchases New Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James Financial Inc. acquired a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 109,317 shares of the cMay 5 at 3:26 AM | marketbeat.comMarshall Wace LLP Buys Shares of 76,254 Takeda Pharmaceutical Company Limited (NYSE:TAK)Marshall Wace LLP purchased a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 76,254 shares of the company's stock, valued at approximately $1,010,000. A number of other lMay 3, 2025 | marketbeat.comAquatic Capital Management LLC Buys 61,927 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Aquatic Capital Management LLC increased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 180,927 shares of the company's stocMay 1, 2025 | marketbeat.comTakeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand ...April 30, 2025 | gurufocus.comTakeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand STEM EducationApril 30, 2025 | businesswire.comJPMorgan Chase & Co. Has $1.11 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)JPMorgan Chase & Co. boosted its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 94.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,826 shares of the company's stock after purchasiApril 29, 2025 | marketbeat.comSyon Capital LLC Has $486,000 Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Syon Capital LLC lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 41.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,680 shares of the company's stock after selling 25,626 shares during the period. SApril 27, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Mariner LLCMariner LLC raised its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 14.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 142,504 shares of the company's stock after purchasing anApril 27, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Purchased by First Trust Advisors LPFirst Trust Advisors LP boosted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,240,932 shares of the company's stock afteApril 26, 2025 | marketbeat.comXTX Topco Ltd Trims Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)XTX Topco Ltd decreased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 63.6% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 24,492 shares of the company's stock after selling 42,794 shares duriApril 26, 2025 | marketbeat.comJapanese pharmaceutical firm Takeda’s profits hit by €37m impairment chargeApril 24, 2025 | msn.comCapital Research Global Investors Buys 25,309 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Capital Research Global Investors raised its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 0.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,162,513 shares of the coApril 23, 2025 | marketbeat.comSterling Capital Management LLC Cuts Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Sterling Capital Management LLC cut its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 61.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,123April 23, 2025 | marketbeat.comHow Takeda's CEO transformed the company into a global pharma powerhouseApril 23, 2025 | msn.comForum Financial Management LP Acquires 65,399 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Forum Financial Management LP grew its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 133.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 114,324 shares of the company's stock after acquiring aApril 21, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Position Trimmed by Cerity Partners LLCCerity Partners LLC reduced its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 31.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 87,651 shares of the company's sApril 21, 2025 | marketbeat.comEnvestnet Asset Management Inc. Sells 460,843 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Envestnet Asset Management Inc. reduced its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 31.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 984,678 shares of the comApril 19, 2025 | marketbeat.comCholesterol-modified oligonucleotides show promise for treating brain diseasesApril 17, 2025 | msn.comKorea's Takeda Pharmaceutical Appoints Kim Mi-seung, New Director of Anti-cancer Drug Business DivisionApril 17, 2025 | msn.comWells Fargo & Company MN Has $11.44 Million Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Wells Fargo & Company MN cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 11.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 863,678 shares of the company's stock after selling 114,324April 17, 2025 | marketbeat.comCauseway Capital Management LLC Sells 759,162 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Causeway Capital Management LLC decreased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 59.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 522,030 shaApril 16, 2025 | marketbeat.com200+ Healthcare Industry Leaders Unite at Komodo Health's The One Day Summit to Accelerate Innovation Amid DisruptionApril 15, 2025 | tmcnet.comTakeda Completes Significant Share Repurchase in March 2025April 14, 2025 | tipranks.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Stock Holdings Decreased by Federated Hermes Inc.Federated Hermes Inc. decreased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 19.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 435,034 shares of the company's stock after selling 107,719 shares duringApril 14, 2025 | marketbeat.comRenaissance Technologies LLC Trims Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Renaissance Technologies LLC reduced its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,079April 13, 2025 | marketbeat.comChina Approves First Hemophilia B Gene Therapy by Belief BioMed and TakedaApril 11, 2025 | msn.comNMPA approves BBM and Takeda China’s haemophilia B therapyApril 11, 2025 | finance.yahoo.comPharma Stocks Tumble After Trump Threatens Tariffs on MedicinesApril 9, 2025 | wsj.comBioInvent International: BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3April 8, 2025 | finanznachrichten.deAmerican Century Companies Inc. Purchases 17,103 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)American Century Companies Inc. grew its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 6.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 301,087 shares of the company's stock afApril 7, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Sets New 1-Year High - Should You Buy?Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - Time to Buy?April 5, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Sei Investments Co.Sei Investments Co. lowered its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 29.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 222,887 shares of the company's stock after selling 93,071 shares during theApril 5, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Rating Increased to Overweight at Morgan StanleyMorgan Stanley raised Takeda Pharmaceutical from an "equal weight" rating to an "overweight" rating in a report on Wednesday.April 4, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Sells 419,019 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Arrowstreet Capital Limited Partnership reduced its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional invApril 3, 2025 | marketbeat.comRaymond James Financial Inc. Invests $1.45 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James Financial Inc. bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 109,317 shares of the company's stock, valued at approximately $1,447,April 3, 2025 | marketbeat.comTakeda upgraded to Overweight from Equal Weight at Morgan StanleyApril 2, 2025 | markets.businessinsider.comHarmony Biosciences Names Adam Zaeske as Chief Commercial OfficerMarch 30, 2025 | msn.comTakeda Canada says Health Canada expands marketing authorization for HyQviaMarch 28, 2025 | markets.businessinsider.comCharles Schwab Investment Management Inc. Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Charles Schwab Investment Management Inc. boosted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 35.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 253,551 shares of the comMarch 28, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Time to Buy?Takeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Should You Buy?March 25, 2025 | marketbeat.comSummit Global Investments Has $9.66 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Summit Global Investments lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 75.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 729,200 shares of the comMarch 23, 2025 | marketbeat.com69,083 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Bought by Boston PartnersBoston Partners bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 69,083 shares of the company's stoMarch 23, 2025 | marketbeat.comNatixis Advisors LLC Acquires 21,539 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Natixis Advisors LLC lifted its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 4.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 478,579 shares of theMarch 23, 2025 | marketbeat.comSignaturefd LLC Raises Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Signaturefd LLC boosted its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 43.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,097 shares of the cMarch 21, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - What's Next?Takeda Pharmaceutical (NYSE:TAK) Sets New 12-Month High - Time to Buy?March 18, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Position Lowered by Brandes Investment Partners LPBrandes Investment Partners LP decreased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 5.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,039,585 shares of the company's stock after selling 192,019 sharMarch 16, 2025 | marketbeat.comJapan union group says gained hefty average 2025 pay hike, albeit less than last yearMarch 14, 2025 | msn.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼1.010.68▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼84▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today ARGX News Today ONC News Today BNTX News Today SMMT News Today TEVA News Today ITCI News Today GMAB News Today RDY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
